Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

MACD Volume

Score

0.6

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 37 10.9 0.46% 0.65% 7.1% -6.0% -35.6%
SHORT 36 10.0 0.64% 1.35% 7.6% -4.6% 96.1%

Summary

Technical Analysis

Cogstate (CGS.AX)


Indicator:

VOLUME MACD


Last Signal:

BULLISH


Trading: HOLD @ $0.285
Signal Strength: MEDIUM
Recommendation:

Cogstate (ASX:CGS) currently has positive Volume MACD of 3418. This means the signal line is greater than the Volume MACD line signalling a bullish movement.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement


Volume Moving Average Convergence/Divergence (VMACD) is an indicator that shows the relationship between two moving averages. It is calculated as a difference between the fast and slow moving averages. The historically popular is the difference between a securities 26-day and 12-day Exponential Moving Averages (EMA).

Calculation: Moving Average Convergence Divergence Volume (VMACD):
1) VMACD Line: (12-day EMA - 26-day EMA);
2) Signal Line: 9-day EMA of VMACD Line;
3) VMACD Histogram: VMACD Line - Signal Line;


PROFILE: Cogstate (CGS.AX)


Stock Exchange: ASX
Company: Cogstate
Ticker Codes: | CGS.AX | ASX:CGS |

About Cogstate (ASX:CGS):

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.

Top 10:

MACD Volume

Download
Company Close Change(%) Volume Value Signal
MOC Mortgage Choice 0.91 14.5 663,230 51,567 BULLISH
MPL Medibank Private 3.21 11.5 23,800,298 1,465,447 BULLISH
GNG GR Engineering Services 0.95 9.8 41,600 3,433 BULLISH
MNY Money3 2.21 9.4 151,763 13,251 BULLISH
WBC Westpac Banking Corporation 27.75 9.2 24,404,464 1,511,960 BULLISH
ALK Alkane Exploration 0.24 9.1 1,447,163 204,688 BULLISH
AHG Advance Healthcare 2.55 9 1,585,387 151,695 BULLISH
OVH Onevue Holdings 0.49 8.9 426,122 44,553 BULLISH
NAB National Australia Bank 25.81 7.9 23,451,421 1,340,497 BULLISH
ANZ Australia & Banking 27.86 7.8 14,554,708 867,930 BULLISH